Teladoc Health Inc. (TDOC) saw its stock soar 5.05% in Monday's after-hours trading, driven by the announcement of a new collaboration with Amazon to expand access to Teladoc's industry-leading chronic condition management programs.
The partnership enables eligible Amazon customers to seamlessly discover and enroll in Teladoc's cardiometabolic programs for diabetes, hypertension, pre-diabetes, and weight management directly through Amazon's Health Benefits Connector. This move aims to improve access to needed care and help people manage their health in an easier and more convenient way.
"This partnership helps deliver on our strategy to bring greater value to our customers in our individual solutions and across our integrated offerings," said Chuck Divita, Chief Executive Officer of Teladoc Health. "By enabling customers to discover and enroll in our programs on Amazon, this effort will improve access to needed care and help people manage their health in an easier and more convenient way."
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。